Francesca Setaro

Francesca Setaro

Auto-generated profile, based on publicly available information

Francesca Setaro

Universidad Autónoma de Madrid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2017 in Organic & Biomolecular Chemistry
Verified
Journal Article
Open access
PDF file
RRRubén Ruiz
Rubén Ruiz
FSFrancesca Setaro
Francesca Setaro
ÒGÒscar Gulías
Òscar Gulías
Montserrat AgutMontserrat Agut
Montserrat Agut
UHUwe Hahn
Uwe Hahn
SNSanti Nonell
Santi Nonell
Synthesis, photophysical properties and photoantimicrobial efficiency of cationic Zn(ii) and Ru(ii) dendrimeric phthalocyanines.

30 April 2019 in Precision Nanomedicine
Verified
Journal Article
Open access
PDF file
SBShubhadeep Banerjee
Shubhadeep Banerjee
JSJayeeta Sengupta
Jayeeta Sengupta
AAAna Isabel Aljarilla
Ana Isabel Aljarilla
FSFrancesca Setaro
Francesca Setaro
PMPetri Makinen
Petri Makinen
SKSilke Krol
Silke Krol
Diseases caused by obstruction or rupture of vulnerable plaques in the arterial walls such as cardiovascular infarction or stroke are the leading cause of death in the world. In the present work, we developed human serum albumin nanoparticles loaded by physisorption with zinc phthalocyanine, TT1, mainly used for industrial application as near-infrared photosensitizer and compared these to HSA NPs loaded with the well-known silicone phthalocyanine (Pc4). The use of NIR light allows for better tissue penetration, while the use of nanoparticles permits high local concentrations. The particles were characterized and tested for toxicity and stability as well as for their potential use as a contrast agent and NIR photosensitizer for photodynamic therapy in cardiovascular disease. We focused on the distribution of the nanoparticles in RAW264.7 macrophage cells and atherosclerotic mice. The nanoparticles had an average size of 120 nm according to dynamic light scattering, good loading capacity for zinc phthalocyanine, and satisfying stability in 50% (v/v) fetal bovine serum for 8 hours and in an aqueous environment at 4°C for 4–6 weeks. Under light irradiation we found a high production of singlet oxygen and the products showed no dark toxicity in vitro with macrophages (the target cells in vulnerable plaques), but at a low g/mL nanoparticle concentration killed efficiently the macrophages upon LED illumination. Injection of the contrast agent in atherosclerotic mice led to a visible fluorescence signal of zinc phthalocyanine in the atherosclerotic plaque at 30 minutes and in the lungs with a fast clearance of the nanoparticles. Zinc phthalocyanine loaded human serum albumin nanoparticles present an interesting candidate for the visualization and potentially photodynamic treatment of macrophages in atherosclerotic plaques.